Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geron CorpfiledCriticalGeron Corp
Publication of AR122993A1publicationCriticalpatent/AR122993A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
Reivindicación 1: Una composición formulada para administración subcutánea, donde la composición comprende: un inhibidor de telomerasa que comprende un oligonucleótido y una porción lipídica ligada al extremo 5 y/o 3 del oligonucleótido; y una enzima hialuronidasa.Claim 1: A composition formulated for subcutaneous administration, wherein the composition comprises: a telomerase inhibitor comprising an oligonucleotide and a lipid portion ligated to the 5 and/or 3 end of the oligonucleotide; and a hyaluronidase enzyme.
ARP210102008A2020-07-172021-07-16
SUBCUTANEOUS TELOMERASE INHIBITOR, COMPOSITIONS AND METHODS FOR USE THEREOF
AR122993A1
(en)
Compounds derived from thienopyridine, inhibitors of the hiv integrase enzyme; pharmaceutical composition comprising said compounds; and its use to treat an HIV infection.
MICROORGANISM OF THE GENUS CORYNEBACTERIUM THAT PRODUCES L-AMINO ACID, METHOD FOR PRODUCING L-AMINO ACID, USE OF L-AMINO ACID PRODUCTION AND COMPOSITION FOR PRODUCING L-AMINO ACID